Predicting Cervical Cancer Response to Radiotherapy
Author Information
Author(s): C.M.L. West, S.E. Davidson, S.A. Roberts, R.D. Hunter
Primary Institution: Paterson Institute for Cancer Research and Christie Hospital (NHS Trust)
Hypothesis
Can intrinsic radiosensitivity predict patient response to radiotherapy for cervical carcinoma?
Conclusion
Intrinsic radiosensitivity is important in determining treatment outcomes for cervical carcinoma treated with radiotherapy.
Supporting Evidence
- Patients with radioresistant tumors had a significantly lower 3-year survival rate than those with sensitive tumors.
- The frequency of local recurrence was higher in patients with radioresistant tumors.
- Patients alive and well had a mean SF2 value significantly lower than those with locoregional failure.
Takeaway
This study found that how sensitive cervical cancer cells are to radiation can help doctors predict how well patients will respond to treatment.
Methodology
Patients with cervical carcinoma were treated with radical radiotherapy, and their tumors' radiosensitivity was measured using a soft agar clonogenic assay.
Limitations
The study only included women with stage I, II, and III disease and had a success rate of 73% for obtaining SF2 values.
Participant Demographics
All participants were women with cervical carcinoma, specifically stages I, II, and III.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website